The 2025 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium will take place from February 13-15, 2025, at Moscone West in San Francisco, CA. This prestigious event will offer attendees expert, multidisciplinary insights into the most recent clinical and scientific breakthroughs in the field of genitourinary cancers. Moreover, the symposium will provide a unique opportunity to interact with peers and industry thought leaders, creating a conducive environment for networking and collaboration.
To secure your attendance at this esteemed event, we highly recommend registering promptly by clicking this link. By doing so, you will have the chance to secure accommodations, access travel information, plan your itinerary, and guarantee your participation in educational and networking activities before they reach full capacity.
Below, you will find a list of sessions that we are eagerly looking forward to at #GU25. The sessions are organized in chronological order for your convenience.
Understanding Radioligand Therapies for Advanced Prostate Cancer
- Date/Time: Thursday, February 13, 2025, 10:10 AM-11:25 AM PST
- Presentations include:
- PSMA-Based Therapy in Advanced Disease: Touching on Combination Sequencing
- Beyond PSMA-Targeted Agents for Advanced Disease
- Seeing Is Believing: Radiographic Criteria to Assess Response
Case-Based Session: Management of Biochemical Recurrence After Radiation Therapy for Localized Prostate Cancer
- Date/Time: Thursday, February 13, 2025,12:45 PM-2:00 PM PST
- Presentations include:
- Recurrence After Radiation Therapy: Evaluation, Management, and Outcomes
- The Impact of Salvage Therapies: Functional Outcomes and Quality of Life
Breakout Session: Emerging Trends and Advances in Germ Cell Tumors
- Date/Time: Friday, February 14, 2025, 11:40 AM-12:35 PM PST
- Presentations include:
- High-Dose Chemotherapy in Testicular Cancer: Current Evidence and Clinical Indications
- Primary Retroperitoneal Lymph Node Dissection in Stage II Seminoma: Management Strategies and Current Controversies
- Landscape of New Trials and Targets in Refractory Germ Cell Tumors
The ABCs of ADCs: Unleashing the Power of Antibody-Drug Conjugates in Advanced Bladder Cancer
- Date/Time: Friday, February 14, 2025, 12:45 PM-2:00 PM PST
- Presentations include:
- Targeting Bladder Cancer With Antibody Drug Conjugates
- HER2 Antibody-Drug Conjugate Therapy: A New Frontier in Bladder Cancer
- Overcoming Challenges of Antibody-Drug Conjugate Toxicity in Bladder Cancer
- Better Together? Exploring Novel Drug Combinations With Antibody-Drug Conjugates
Panning for Gold: The Role of ctDNA as a Biomarker for Bladder Cancer
- Date/Time: Friday, February 14, 2025, 2:30 PM-3:45 PM PST
- Presentations include:
- Capturing What You Cannot See: How Can ctDNA Be Used to Improve Clinical Staging for Upper Tract Disease?
- Evolution of Ctdna Detection with Next Generation Technology
- Potential Impact of ctDNA on Perioperative Management of Muscle-Invasive Bladder Cancer
- Beneath the Surface: Unleashing the Potential of Ctdna across the Spectrum of Urothelial Carcinoma
To Treat or Not to Treat: Debating Adjuvant Therapy for Resectable Hepatocellular Carcinoma and Exploring Optimal Management Strategies for Intermediate-Stage Hepatocellular Carcinoma
- Date/Time: Saturday, February 15, 2025, 10:15 AM-11:30 AM PST
- Presentations include:
- Biomarkers in Renal Cell Carcinoma: Dead End or Turning Point?
- The Future of Biomarkers in Renal Cell Carcinoma
- Adjuvant Therapy in Renal Cell Cancer: A Practical Guide
The 2025 ASCO GU Cancers Symposium is set to be an enriching and informative event. We recommend clicking here to explore the comprehensive list of topics and sessions that will be covered at this significant event. Don’t miss the opportunity to expand your expertise — register today. See you in San Francisco!
Sign up for alerts and stay informed on the latest published guidelines and stay tuned for our recap post the conference.
Copyright © 2025 Guideline Central, All Rights Reserved.